Yokogawa Releases SU10 Single Cellome Unit for Use in Biological Resea…

Yokogawa Electric Corporation (TOKYO: 6841) announces that it has developed the SU10 Single Cellome™ Unit, a device that uses a nanopipette[*1] to inject substances such as genes and drugs and aspirate intracellular materials at target locations in individual cells. Targeting the biological research market, the SU10 is being released on this date in Japan, with release in other markets such as the US to follow at a later date. Through the development of such solutions, Yokogawa’s life inn...